SARTORIUS AG (SRT.DE) Stock Fundamental Analysis
FRA:SRT - Deutsche Boerse Ag - DE0007165607 - Common Stock - Currency: EUR
We assign a fundamental rating of 3 out of 10 to SRT. SRT was compared to 18 industry peers in the Life Sciences Tools & Services industry. Both the profitability and financial health of SRT have multiple concerns. While showing a medium growth rate, SRT is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
In the past year SRT was profitable.
In the past year SRT had a positive cash flow from operations.
SRT had positive earnings in each of the past 5 years.
SRT had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
SRT has a Return On Assets of 0.94%. This is in the lower half of the industry: SRT underperforms 72.22% of its industry peers.
Looking at the Return On Equity, with a value of 3.52%, SRT is doing worse than 66.67% of the companies in the same industry.
SRT has a Return On Invested Capital of 3.51%. This is in the lower half of the industry: SRT underperforms 72.22% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for SRT is in line with the industry average of 6.84%.
The last Return On Invested Capital (3.51%) for SRT is well below the 3 year average (8.34%), which needs to be investigated, but indicates that SRT had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.94% | ||
| ROE | 3.52% | ||
| ROIC | 3.51% |
ROA(3y)4.22%
ROA(5y)4.59%
ROE(3y)15.69%
ROE(5y)18.55%
ROIC(3y)8.34%
ROIC(5y)10.45%
1.3 Margins
SRT has a Profit Margin of 2.77%. This is in the lower half of the industry: SRT underperforms 72.22% of its industry peers.
In the last couple of years the Profit Margin of SRT has declined.
With a Operating Margin value of 11.82%, SRT is not doing good in the industry: 61.11% of the companies in the same industry are doing better.
In the last couple of years the Operating Margin of SRT has declined.
Looking at the Gross Margin, with a value of 45.27%, SRT is in the better half of the industry, outperforming 77.78% of the companies in the same industry.
SRT's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 11.82% | ||
| PM (TTM) | 2.77% | ||
| GM | 45.27% |
OM growth 3Y-21.14%
OM growth 5Y-7.77%
PM growth 3Y-35.47%
PM growth 5Y-21.95%
GM growth 3Y-5.43%
GM growth 5Y-2.63%
2. Health
2.1 Basic Checks
SRT has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, SRT has more shares outstanding
SRT has more shares outstanding than it did 5 years ago.
SRT has a better debt/assets ratio than last year.
2.2 Solvency
SRT has an Altman-Z score of 1.93. This is not the best score and indicates that SRT is in the grey zone with still only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 1.93, SRT is not doing good in the industry: 72.22% of the companies in the same industry are doing better.
The Debt to FCF ratio of SRT is 6.50, which is on the high side as it means it would take SRT, 6.50 years of fcf income to pay off all of its debts.
SRT has a worse Debt to FCF ratio (6.50) than 61.11% of its industry peers.
A Debt/Equity ratio of 1.55 is on the high side and indicates that SRT has dependencies on debt financing.
SRT's Debt to Equity ratio of 1.55 is on the low side compared to the rest of the industry. SRT is outperformed by 83.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.55 | ||
| Debt/FCF | 6.5 | ||
| Altman-Z | 1.93 |
ROIC/WACC0.48
WACC7.25%
2.3 Liquidity
A Current Ratio of 1.46 indicates that SRT should not have too much problems paying its short term obligations.
SRT has a Current ratio of 1.46. This is comparable to the rest of the industry: SRT outperforms 50.00% of its industry peers.
A Quick Ratio of 0.93 indicates that SRT may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.93, SRT is doing worse than 72.22% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.46 | ||
| Quick Ratio | 0.93 |
3. Growth
3.1 Past
The earnings per share for SRT have decreased strongly by -36.23% in the last year.
The earnings per share for SRT have been decreasing by -11.87% on average. This is quite bad
SRT shows a small growth in Revenue. In the last year, the Revenue has grown by 3.99%.
The Revenue has been growing by 13.10% on average over the past years. This is quite good.
EPS 1Y (TTM)-36.23%
EPS 3Y-36.07%
EPS 5Y-11.87%
EPS Q2Q%30.97%
Revenue 1Y (TTM)3.99%
Revenue growth 3Y-0.67%
Revenue growth 5Y13.1%
Sales Q2Q%7.74%
3.2 Future
Based on estimates for the next years, SRT will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.27% on average per year.
Based on estimates for the next years, SRT will show a quite strong growth in Revenue. The Revenue will grow by 8.50% on average per year.
EPS Next Y22.89%
EPS Next 2Y24.43%
EPS Next 3Y26.21%
EPS Next 5Y19.27%
Revenue Next Year6.37%
Revenue Next 2Y7.98%
Revenue Next 3Y8.7%
Revenue Next 5Y8.5%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
SRT is valuated quite expensively with a Price/Earnings ratio of 40.42.
SRT's Price/Earnings ratio is a bit more expensive when compared to the industry. SRT is more expensive than 66.67% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.48. SRT is valued slightly more expensive when compared to this.
With a Price/Forward Earnings ratio of 27.20, SRT can be considered very expensive at the moment.
The rest of the industry has a similar Price/Forward Earnings ratio as SRT.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.52, SRT is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 40.42 | ||
| Fwd PE | 27.2 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as SRT.
Based on the Price/Free Cash Flow ratio, SRT is valued a bit cheaper than the industry average as 72.22% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 18.14 | ||
| EV/EBITDA | 20.01 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
SRT's earnings are expected to grow with 26.21% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.77
PEG (5Y)N/A
EPS Next 2Y24.43%
EPS Next 3Y26.21%
5. Dividend
5.1 Amount
SRT has a yearly dividend return of 0.40%, which is pretty low.
Compared to an average industry Dividend Yield of 0.71, SRT has a dividend in line with its industry peers.
With a Dividend Yield of 0.40, SRT pays less dividend than the S&P500 average, which is at 2.34.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.4% |
5.2 History
The dividend of SRT has a limited annual growth rate of 3.71%.
Dividend Growth(5Y)3.71%
Div Incr Years3
Div Non Decr Years3
5.3 Sustainability
SRT pays out 53.09% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of SRT is growing, but earnings are growing more, so the dividend growth is sustainable.
DP53.09%
EPS Next 2Y24.43%
EPS Next 3Y26.21%
FRA:SRT (7/18/2025, 12:23:47 PM)
172.6
+0.2 (+0.12%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners4.37%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap12.92B
Analysts77.14
Price Target292.74 (69.61%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.4% |
Yearly Dividend0.74
Dividend Growth(5Y)3.71%
DP53.09%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-4.1%
Min EPS beat(2)-4.13%
Max EPS beat(2)-4.06%
EPS beat(4)1
Avg EPS beat(4)-0.94%
Min EPS beat(4)-22.4%
Max EPS beat(4)26.82%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)3.77%
Min Revenue beat(2)2.67%
Max Revenue beat(2)4.87%
Revenue beat(4)3
Avg Revenue beat(4)1.54%
Min Revenue beat(4)-4.07%
Max Revenue beat(4)4.87%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-0.35%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-4.26%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.86%
Revenue NQ rev (1m)-0.78%
Revenue NQ rev (3m)-1.12%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.2%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 40.42 | ||
| Fwd PE | 27.2 | ||
| P/S | 3.75 | ||
| P/FCF | 18.14 | ||
| P/OCF | 12.08 | ||
| P/B | 4.77 | ||
| P/tB | N/A | ||
| EV/EBITDA | 20.01 |
EPS(TTM)4.27
EY2.47%
EPS(NY)6.35
Fwd EY3.68%
FCF(TTM)9.51
FCFY5.51%
OCF(TTM)14.29
OCFY8.28%
SpS45.99
BVpS36.19
TBVpS-35.83
PEG (NY)1.77
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.94% | ||
| ROE | 3.52% | ||
| ROCE | 4.72% | ||
| ROIC | 3.51% | ||
| ROICexc | 3.9% | ||
| ROICexgc | 12.82% | ||
| OM | 11.82% | ||
| PM (TTM) | 2.77% | ||
| GM | 45.27% | ||
| FCFM | 20.68% |
ROA(3y)4.22%
ROA(5y)4.59%
ROE(3y)15.69%
ROE(5y)18.55%
ROIC(3y)8.34%
ROIC(5y)10.45%
ROICexc(3y)8.77%
ROICexc(5y)11.17%
ROICexgc(3y)24.37%
ROICexgc(5y)31.52%
ROCE(3y)11.22%
ROCE(5y)14.06%
ROICexcg growth 3Y-35.26%
ROICexcg growth 5Y-11.95%
ROICexc growth 3Y-38.49%
ROICexc growth 5Y-19.53%
OM growth 3Y-21.14%
OM growth 5Y-7.77%
PM growth 3Y-35.47%
PM growth 5Y-21.95%
GM growth 3Y-5.43%
GM growth 5Y-2.63%
F-Score7
Asset Turnover0.34
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.55 | ||
| Debt/FCF | 6.5 | ||
| Debt/EBITDA | 5.06 | ||
| Cap/Depr | 84.42% | ||
| Cap/Sales | 10.39% | ||
| Interest Coverage | 1.93 | ||
| Cash Conversion | 128.78% | ||
| Profit Quality | 745.86% | ||
| Current Ratio | 1.46 | ||
| Quick Ratio | 0.93 | ||
| Altman-Z | 1.93 |
F-Score7
WACC7.25%
ROIC/WACC0.48
Cap/Depr(3y)148.03%
Cap/Depr(5y)150.65%
Cap/Sales(3y)13.71%
Cap/Sales(5y)12.64%
Profit Quality(3y)282.77%
Profit Quality(5y)224.27%
High Growth Momentum
Growth
EPS 1Y (TTM)-36.23%
EPS 3Y-36.07%
EPS 5Y-11.87%
EPS Q2Q%30.97%
EPS Next Y22.89%
EPS Next 2Y24.43%
EPS Next 3Y26.21%
EPS Next 5Y19.27%
Revenue 1Y (TTM)3.99%
Revenue growth 3Y-0.67%
Revenue growth 5Y13.1%
Sales Q2Q%7.74%
Revenue Next Year6.37%
Revenue Next 2Y7.98%
Revenue Next 3Y8.7%
Revenue Next 5Y8.5%
EBIT growth 1Y-9.05%
EBIT growth 3Y-21.66%
EBIT growth 5Y4.31%
EBIT Next Year103.14%
EBIT Next 3Y38.58%
EBIT Next 5Y26.99%
FCF growth 1Y303.11%
FCF growth 3Y7.25%
FCF growth 5Y29.73%
OCF growth 1Y44.89%
OCF growth 3Y4.07%
OCF growth 5Y20.79%